Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Cottu

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Bulletin Du Cancer|May 12, 2020
[Impact of the COVID-19 epidemic on requests for initial care for breast cancer]Delphine Héquet, Manuel Rodrigues, Anne Tardivon, et al.
The Breast Journal|April 14, 2025
Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal CarcinomatosisGrégoire Narjoux, Juliette Mainguené, Marie-Noëlle Guilhaume, et al.
Diagnostic and Interventional Imaging|May 11, 2021
CT-guided vertebroplasty of first (C1) or second (C2) cervical vertebra using an electromagnetic navigation system and a transoral approachBenjamin Moulin, Herve Brisse, Guillaume Dutertre, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patientsCyrus Chargari, Hind Riahi Idrissi, Jean-Yves Pierga, et al.
Breast (Edinburgh, Scotland)|March 14, 2026
Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancerAdam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Breast (Edinburgh, Scotland)|April 5, 2026
Corrigendum to "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer" [The Breast 86 (2026) 104744]Adam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Archives of Internal Medicine|August 3, 2002
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled studyGuy Meyer, Zora Marjanovic, Judith Valcke, et al.
Bulletin Du Cancer|August 2, 2021
[Adapting to the SARS-CoV2 pandemic: Experience of the Curie Institute]Elisabeth Lucchi-Angellier, Jean-Christophe Mino, Alexis Burnod, et al.
Breast Cancer Research : BCR|February 15, 2012
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational studyFrançois-Clément Bidard, David Hajage, Thomas Bachelot, et al.
Breast (Edinburgh, Scotland)|February 8, 2022
Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trialPaul Cottu, Alistair Ring, Hikmat Abdel-Razeq, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Bulletin Du Cancer|May 12, 2020
[Impact of the COVID-19 epidemic on requests for initial care for breast cancer]Delphine Héquet, Manuel Rodrigues, Anne Tardivon, et al.
The Breast Journal|April 14, 2025
Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal CarcinomatosisGrégoire Narjoux, Juliette Mainguené, Marie-Noëlle Guilhaume, et al.
Diagnostic and Interventional Imaging|May 11, 2021
CT-guided vertebroplasty of first (C1) or second (C2) cervical vertebra using an electromagnetic navigation system and a transoral approachBenjamin Moulin, Herve Brisse, Guillaume Dutertre, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patientsCyrus Chargari, Hind Riahi Idrissi, Jean-Yves Pierga, et al.
Breast (Edinburgh, Scotland)|March 14, 2026
Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancerAdam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Breast (Edinburgh, Scotland)|April 5, 2026
Corrigendum to "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer" [The Breast 86 (2026) 104744]Adam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Archives of Internal Medicine|August 3, 2002
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled studyGuy Meyer, Zora Marjanovic, Judith Valcke, et al.
Bulletin Du Cancer|August 2, 2021
[Adapting to the SARS-CoV2 pandemic: Experience of the Curie Institute]Elisabeth Lucchi-Angellier, Jean-Christophe Mino, Alexis Burnod, et al.
Breast Cancer Research : BCR|February 15, 2012
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational studyFrançois-Clément Bidard, David Hajage, Thomas Bachelot, et al.
Breast (Edinburgh, Scotland)|February 8, 2022
Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Subgroup analysis of the phase IIIb CompLEEment-1 trialPaul Cottu, Alistair Ring, Hikmat Abdel-Razeq, et al.
Pageof 14